Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1487688

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1487688

Cannabidiol (CBD) Oil Market - By Source (Hemp, Marijuana), Product Type (Original, Blended), Product Category (Flavoured, Unflavoured), Application (Nutraceuticals, Pharmaceuticals), Formulation, Distribution Channel, Global Forecast 2024 - 2032

PUBLISHED:
PAGES: 225 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

Global Cannabidiol (CBD) Oil Market Size will witness 18.6% CAGR between 2024 and 2032, driven by increasing research and development efforts focused on uncovering its potential benefits. As scientific studies continue to shed light on CBD's therapeutic properties, including its potential to alleviate pain, reduce anxiety, and mitigate symptoms of various medical conditions, consumer interest in CBD products is growing exponentially.

For instance, in February 2024, new research from CU Boulder suggested that cannabis products high in CBD may be more effective at reducing anxiety than those dominated by THC and without the potential side effects. Published in Cannabis and Cannabinoid Research, the study involving 300 participants was the first randomized trial to explore the impact of legally available cannabis on anxiety symptoms.

Moreover, regulatory changes and increasing legalization of cannabis-derived products in various regions contribute to the market's expansion. As consumers seek natural remedies and alternatives to traditional pharmaceuticals, CBD oil emerges as a promising option. This rising demand underscores a paradigm shift towards holistic wellness practices and fuels innovation in the CBD industry, propelling its growth trajectory.

The overall Cannabidiol (CBD) Oil Industry is classified based on the source, product type, product category, application, formulation, distribution channel, and region.

The marijuana segment will undergo groundbreaking development from 2024 to 2032. Derived from the cannabis plant, CBD oil has gained popularity for its potential therapeutic benefits without the psychoactive effects of THC, another compound found in marijuana. As attitudes towards marijuana shift and legalization efforts progress globally, the market for CBD oil expands. Consumers seek natural remedies for various ailments, contributing to the growing demand for CBD products. Additionally, advancements in extraction techniques and product formulations enhance the appeal of CBD oil, driving its market growth within the broader marijuana industry.

The cannabidiol (CBD) oil market share from the blended segment will register a noteworthy CAGR from 2024 to 2032. Blending CBD oil with other natural compounds or ingredients enhances its versatility and effectiveness, catering to diverse consumer preferences and needs. Whether combined with essential oils for aromatherapy benefits or infused with vitamins and nutrients for added health benefits, blended CBD oil products offer a holistic approach to wellness. These blends provide consumers with a convenient and customizable solution to address various health concerns, from stress relief to skin care. As the market continues to innovate and diversify, the demand for blended CBD oil products could grow, shaping the industry growth outlook.

Europe cannabidiol (CBD) oil market will showcase an appreciable CAGR from 2024 to 2032. As regulatory frameworks evolve and public perception towards cannabis-derived products shifts, the market for CBD oil expands rapidly. Consumers in Europe are increasingly seeking natural remedies for various health concerns, driving the demand for CBD oil products. Moreover, the wellness and skincare industries are embracing CBD oil for its purported benefits, further fueling market growth. With increasing accessibility and a wide range of product offerings, including oils, capsules, and topicals, the demand for CBD oil in Europe could continue its upward trajectory.

Product Code: 8545

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing medical applications of CBD
      • 3.2.1.2 Growing preference for CBD over conventional pharmaceuticals
      • 3.2.1.3 Changing regulatory landscape for approval of CBD products
      • 3.2.1.4 Increasing sales of CBD products in retail stores
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Side effects associated with CBD oil
      • 3.2.2.2 Counterfeit and synthetic products available in the market
      • 3.2.2.3 Regulatory uncertainties
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Source, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Hemp
  • 5.3 Marijuana

Chapter 6 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Original
  • 6.3 Blended

Chapter 7 Market Estimates and Forecast, By Product Category, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Flavoured CBD oil
  • 7.3 Unflavoured CBD oil

Chapter 8 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Nutraceuticals
  • 8.3 Pharmaceuticals
    • 8.3.1 Pain management
    • 8.3.2 Anxiety and depression
    • 8.3.3 Sleep disorder
    • 8.3.4 Skin care
    • 8.3.5 Neurological disorders
    • 8.3.6 Other pharmaceutical applications

Chapter 9 Market Estimates and Forecast, By Formulation, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Pills & capsules
  • 9.3 Creams & roll-ons
  • 9.4 Transdermal patches
  • 9.5 Drops
  • 9.6 Other formulations

Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 ($ Million)

  • 10.1 Key trends
  • 10.2 Online
  • 10.3 Offline
    • 10.3.1 Hospital pharmacy
    • 10.3.2 Retail stores

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 11.1 Key trends, by region
  • 11.2 North America
    • 11.2.1 U.S.
    • 11.2.2 Canada
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 France
    • 11.3.4 Spain
    • 11.3.5 Italy
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 Rest of Asia Pacific
  • 11.5 Latin America
    • 11.5.1 Brazil
    • 11.5.2 Mexico
    • 11.5.3 Rest of Latin America
  • 11.6 Middle East and Africa
    • 11.6.1 South Africa
    • 11.6.2 Saudi Arabia
    • 11.6.3 Rest of Middle East and Africa

Chapter 12 Company Profiles

  • 12.1 Aurora Cannabis Inc
  • 12.2 Bluebird Botanicals
  • 12.3 BIOTA Biosciences
  • 12.4 CHARLOTTE'S WEB
  • 12.5 Elixinol
  • 12.6 Endoca
  • 12.7 Evora Worldwide
  • 12.8 Green Roads
  • 12.9 Hempstrol
  • 12.10 Health Horizons
  • 12.11 Medical Mary, LLC
  • 12.12 Medterra CBD
  • 12.13 Neurogan
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!